Physician profile
Gabriella Palma
NPI 1881686624
$5,643.28
in general payments reported to CMS, 2019-2025
42 companies · $1,336 in 2025
The $1,336 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $454 · 2021: $419 · 2022: $732 · 2023: $965 · 2024: $1,002 · 2025: $1,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,302.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,042.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $658.09 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $528.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $499.42 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $360.10 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Novo Nordisk INC | $338.62 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $291.46 | 2019-2025 | Evenity, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $220.52 | 2019-2025 | Spravato |
| Exact Sciences Corporation | $190.12 | 2024-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $178.06 | 2019-2025 | Korlym |
| Corium, LLC | $129.35 | 2022-2025 | Azstarys |
| Astellas Pharma US INC | $107.77 | 2024-2025 | Veozah |
| Glaxosmithkline, LLC. | $100.76 | 2020-2025 | Arexvy, Shingrix, Bexsero |
| Sanofi Pasteur INC. | $85.07 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $81.33 | 2023-2025 | Gvoke Hypopen |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriella Palma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.